Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/10/2018
SIETES contiene 92567 citas

 
 
 1 a 13 de 13 
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Hyubrechts KF. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ 2018;360:28 de marzo. [Ref.ID 102642]
2.Enlace a cita original Cita con resumen
Park Y, Hernandez-Diaz S, Bateman BT, Cohen JM, Desai RJ, Patorno E, Glynn RJ, Cohen LS, Mogun H, Huybrechts KF. Continuation of atypical antipsychotic medication during early pregnancy and the risk of gestational diabetes. Am J Psychiatry 2018:7 de mayo. [Ref.ID 102604]
3.Enlace a cita original Cita con resumen
Desai RJ, Bateman BT, Huybrechts KF, Patorno E, Hernández-Díaz S, Park Y, Dejene SZ, Cohen J, Mogun H, Kim SC. Risk of serious infections associated with use of immunosuppressive agents in pregnant women with autoimmune inflammatory conditions: cohort study. BMJ 2017;356:j895. [Ref.ID 101510]
4.Tiene citas relacionadas Cita con resumen
Xiao Q, Murphy RA, Houston DK, Harris TB, Chow W-H, Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP Diet and Health Study. JAMA Intern Med 2013;173:639-46. [Ref.ID 95288]
5. Cita con resumen
Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PFA, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathioiu E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE, for the COU-AA-302 Investigators. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013;368:138-48. [Ref.ID 94745]
6.Tiene citas relacionadas Cita con resumen
Sahasrabuddhe VV, Gunja MZ, Graubard BI, Trabert B, Schwartz LM, Park Y, Hollenbeck AR, Freedman ND, McGlynn KA. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. Journal of National Cancer Institute 2012;104:1808-14. [Ref.ID 93263]
7.Tiene citas relacionadas Cita con resumen
Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffe drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891-904. [Ref.ID 92985]
8.Tiene citas relacionadas
Yeong YH, Park Y, Kim I-S. Standard- vs high-dose clopidogrel after percutaneous coronary intervention. JAMA 2011;305:2520. [Ref.ID 91333]
9. Cita con resumen
Reis JP, Loria CM, Sorlie PD, Park Y, Hollenbeck A, Schatzkin A. Lifestyle factors and risk for new-onset diabetes. A population-based cohort study. Ann Intern Med 2011;155:292-9. [Ref.ID 91077]
10.Tiene citas relacionadas Cita con resumen
Cotreau MM, Stonis L, Dykstra KH, Gandhi T, Gutierrez M, Xu J, Park Y, Burghart PH, Scwertschlag US. Multiple-dose, safety, pharmacokinetics, and pharmacodynamics of a new selective estrogen receptor modulator, ERA-923, in healthy postmenopausal women. J Clin Pharmacol 2002;42:157-65. [Ref.ID 60274]
11.Tiene citas relacionadas
McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995;333:1099-105. [Ref.ID 25030]
12.
Chu SY, Park Y, Locke C, Wilson DS, Cavanaugh JC. Drug-food interaction potential of clarithromycin, a new nacrolide antimicrobial. J Clin Pharmacol 1992;32:32-6. [Ref.ID 16982]
13.
Hoofnagle JH, Mullen KD, Jones B, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986;315:1575-8. [Ref.ID 9753]
Seleccionar todas
 
 1 a 13 de 13